No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	AC0176 Sensitive: B - Late Trials AC0176 Sensitive : B	AC0176 Sensitive: B - Late Trials AC0176 Sensitive : B
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	ONCT-534 Sensitive: B - Late Trials ONCT-534 Sensitive : B	ONCT-534 Sensitive: B - Late Trials ONCT-534 Sensitive : B
AR T878S + AR H875Y	Prostate Cancer	AR T878S + AR H875Y	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR T878A + AR H875Y	Prostate Cancer	AR T878A + AR H875Y	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR H875Y	Prostate Cancer	AR H875Y	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR T878S	Prostate Cancer	AR T878S	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR T878A	Prostate Cancer	AR T878A	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3
AR mutation	Prostate Cancer	AR mutation	Prostate Cancer	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3	ARV-110 Sensitive: C3 – Early Trials ARV-110 Sensitive : C3

Androgen receptor degrader

Associations(8)